Pharma Journalist -

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending finerenone for adults with heart failure with preserved or mildly reduced…
Read More...

Excalipoint Therapeutics and DP Technology have announced a strategic collaboration to develop a new artificial intelligence (AI) platform designed to speed up the discovery of T-cell…
Read More...

Clinical-stage radiopharmaceutical company AdvanCell has raised US$315 million in an oversubscribed Series D financing round to accelerate the development of its targeted cancer…
Read More...

Roche has announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to its supplemental Biologics License Application (sBLA) for Gazyva/Gazyvaro…
Read More...

Merck, known as MSD outside the United States and Canada, has announced positive results from its Phase 3 KEYNOTE-C93 clinical trial evaluating KEYTRUDA (pembrolizumab) as a first-line…
Read More...

Harbour BioMed and Kelun-Biotech have announced that China's National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for…
Read More...

Takeda has announced a long-term collaboration with the Indonesian government to strengthen the country's plasma collection and manufacturing capabilities, with the aim of improving…
Read More...

Cellares and Sonoma Biotherapeutics have announced a new collaboration to automate the manufacturing of SBT-77-7101, an investigational regulatory T cell (Treg) therapy being developed…
Read More...

Novartis has entered into a new collaboration with artificial intelligence company Chai Discovery to accelerate the discovery of therapeutic antibodies using advanced AI technology. The…
Read More...

AstraZeneca has signed an exclusive licensing agreement with China's Dizal Pharmaceutical Co., Ltd. to acquire the worldwide rights to develop and commercialize Zegfrovy…
Read More...